Schindler Holding AG
Schindler Holding AG
- ISIN: CH0024638212
- Land: Schweiz
Nachricht vom 18.05.2021 | 07:25
Schindler elevates Egypt’s new capital city
Schindler Holding AG / Key word(s): Contract
Schindler has been selected to deliver and install a total of 129 high-rise elevators to six office towers currently under construction in Egypt's New Administrative Capital, designed to become a high-tech model for Egypt's future.
The buildings will also be equipped with Schindler PORT technology, which helps guide and transport visitors and office workers quickly and safely to their individual floors, while optimizing traffic flow throughout the buildings.
'The grandiose new capital city of Egypt will feature the latest technology that will turn it into one of the major sustainable, smart city projects across the Middle East,' said Chang Weicai, General Manager of China State Construction Engineering Corporate Egypt (CSCEC Egypt), the general contractor for this project. 'Schindler products including Schindler PORT technology will contribute vastly to the new capital's smart and human-centric urban mobility.'
The city, known simply as the New Administrative Capital, will be Egypt's first smart city, covering 700 square kilometers in the desert east of Cairo, making it the size of Singapore. Designed as the country's new administrative hub, it is expected to house 6.5 million people. Its official opening is planned for the end of 2021.
'Schindler has been a pioneer in vertical transportation for almost 150 years and we are as committed as ever to being at the forefront of our industry,' said Thomas Oetterli, Schindler's CEO. 'I am proud that our cutting-edge technology will help transport people in Egypt's new capital sustainably, safely and efficiently.'
End of ad hoc announcement
|Company:||Schindler Holding AG|
|Listed:||SIX Swiss Exchange|
|EQS News ID:||1197538|
|End of Announcement||EQS Group News Service|
GBC im Fokus
IGEA Pharma N.V. Realignment to CBD extraction
The goal is to become the quality and cost leader in the field of CBD in Europe. To this end, a GMP pharma compliant plant is being built in Switzerland. The supercritical CO2 extraction process is to be used to achieve the highest standard of quality. The CBD market is growing strongly and with the focus on quality leadership and pure extraction, IGEA Pharma's new business model should be able to occupy an attractive niche market. With the proprietary supercritical CO2-extraction technology, other markets such as vanilla, rose or rosemary can be developed in the medium term. Based on our DCF model, we have determined a fair value of € 1.05 (CHF 1.13) per share and assign a BUY rating.
Der AKTIONÄR News
04. Dezember 07:00 Einstiegschance voraus! Dieser Hot-Stock plant mit dem "Netflix für ...
04. Dezember 07:15 Bitcoin & Co: Brutaler Abverkauf – ist die Party jetzt vorbei?
04. Dezember 08:00 Top-Tipp Derivate: Luxus in der Warteschleife
04. Dezember 08:05 China-Aktien, Bitcoin & Co: Risiko-Assets werden verkauft
04. Dezember 08:45 Deutsche Telekom: 50 Prozent Potenzial - wann gelingt die Trendwende?
News im Fokus
Allianz SE: Allianz kündigt Abschluss eines Rückversicherungsvertrages in den USA an
03. Dezember 2021, 07:03
FY 2020/2021 Financial Results
16. Dezember 2021
Original-Research: CEWE Stiftung & Co. KGaA (von GSC Research GmbH): Kaufen
02. Dezember 2021